Fagron NV (EBR:FAGR)
Belgium
· Delayed Price · Currency is EUR | Market Cap | 1.53B |
| Revenue (ttm) | 918.75M |
| Net Income (ttm) | 85.69M |
| Shares Out | 73.24M |
| EPS (ttm) | 1.17 |
| PE Ratio | 17.86 |
| Forward PE | 15.09 |
| Dividend | 0.35 (1.69%) |
| Ex-Dividend Date | May 19, 2025 |
| Volume | 42,443 |
| Average Volume | 52,978 |
| Open | 20.70 |
| Previous Close | 20.75 |
| Day's Range | 20.65 - 20.95 |
| 52-Week Range | 15.14 - 23.50 |
| Beta | 0.26 |
| RSI | 52.72 |
| Earnings Date | Feb 12, 2026 |
About Fagron NV
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders, such as vitiligo; Pentravan uses for avoiding first-pass metabolism and preventing gastrointest... [Read more]
Full Company ProfileFinancial Performance
In 2024, Fagron NV's revenue was 871.96 million, an increase of 14.28% compared to the previous year's 762.99 million. Earnings were 80.55 million, an increase of 14.18%.
Financial StatementsNews
Pharma 5.0 delivers personalized treatment using AI, says Fagron CEO
Rafael Padilla, CEO of pharmaceuticals company, Fagron, discusses healthcare innovation, obesity drug safety, and the company's growth strategy amid global pricing pressures.
Fagron Announces Acquisitions Of Amara And Magilab
(RTTNews) - Fagron (FAGR.BR) announced acquisitions of a book of business from Amara, and Magilab. Amara is a player in the compounding sector, operating raw materials in Poland. Magilab is a speciali...
Half Year 2025 Fagron NV Earnings Call Transcript
Half Year 2025 Fagron NV Earnings Call Transcript
Fagron NV (ARSUF) Q3 2025 Sales Call Transcript
Fagron NV (ARSUF) Q3 2025 Sales/ Trading Statement Call - Slideshow
2025-10-09. The following slide deck was published by Fagron NV in conjunction with this event.
Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlook
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 9 October 2025 – 7:00 AM CET Fagron reports solid third quarter performance with 6.4% revenue growth and confi...
Fagron increases share capital through exercise subscription rights
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 June 2025 – 7PM CET Fagron increases share capital through exercise subscription rights Fagron announces that as a result of the ...
Fagron: Recent Capital Markets Day Confirms Upside Potential
Record first-quarter revenue of €239 million, reflecting 14% topline growth
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2025 – 7:00 AM CET Record first-quarter revenue of €239 million, reflecting 14% topline growth Fagron...
Fagron: FDA Warning Letter Creates New Entry Opportunity
Fagron: FDA Warning Letter Creates New Entry Opportunity
Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 10 October 2024 – 7:00 AM CET Fagron reports outstanding third quarter 2024 performance with 12.1% revenue gro...
Record revenue of €209 million in first quarter reflecting 15% topline growth
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 April 2024 – 7:00 AM CET Record revenue of €209 million in first quarter reflecting 15% topline growth Fagr...
Continued strong third quarter performance with 11% topline growth to €191 million
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 12 October 2023 – 7:00 AM CET Continued strong third quarter performance with 11% topline growth to €191 milli...
Fagron NV (ARSUF) Q2 2023 Earnings Call Transcript
Fagron NV (OTC:ARSUF) Q2 2023 Earnings Conference Call August 3, 2023 3:30 AM ET Company Participants Karen Berg - Investor Relations Rafael Padilla - Chief Executive Officer Karin de Jong - Chief Fin...